IPX203-B13-02:Pharmacokinetics of IPX203 and Levodopa formulations in healthy volunteers
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Carbidopa; Entacapone; Entacapone; Levodopa; Levodopa/carbidopa/entacapone
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors IMPAX Laboratories; Impax Pharmaceuticals
- 03 Apr 2014 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 07 Nov 2013 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
- 10 Oct 2013 New trial record